Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Cancer Nanotechnology,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 17, 2025
Emphasizing
the
significance
of
cancer-associated
fibroblasts
(CAFs),
non-malignant
yet
pivotal
players
within
tumor
microenvironment
(TME),
this
review
illuminates
role
inflammatory
subtype
(iCAF)
as
catalysts
in
cancer
proliferation,
metastasis,
and
therapeutic
resistance.
Given
their
paramount
importance,
targeting
CAFs
emerges
a
robust
strategy
evolving
landscape
immunotherapy.
Nanomaterials,
distinguished
by
unique
features
malleability,
hold
considerable
promise
biomedicine,
especially
precision-oriented
domain
therapy.
Their
aptitude
for
modulating
immune
responses,
amplifying
drug
efficacy
through
precise
delivery,
discerningly
focusing
on
cells
TME
situates
nanomaterials
formidable
tools
to
transcend
boundaries
set
conventional
treatments.
This
scrutinizes
convoluted
interplay
among
CAFs,
cells,
TME.
It
further
showcases
widely
utilized
management.
We
underscore
potential
nanoscale
delivery
systems
directed
at
underscoring
transformative
power
revolutionizing
therapies,
enhancing
precision,
culminating
improved
patient
outcomes.
Язык: Английский
Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing
Cancer Cell International,
Год журнала:
2025,
Номер
25(1)
Опубликована: Март 1, 2025
Esophageal
squamous
cell
carcinoma
(ESCC)
is
a
prevalent
and
aggressive
subtype
of
esophageal
cancer,
posing
significant
mortality
economic
burden,
especially
in
East
Southeast
Asia.
Current
therapeutic
strategies
have
limitations
improving
patient
survival,
particularly
regarding
disease
progression
resistance.
This
study
aimed
to
investigate
the
impact
neoadjuvant
chemoradiotherapy
(NCRT)
on
ESCC
microenvironment.
We
utilized
single-cell
RNA
sequencing
systematically
characterize
tumor
cancer-associated
fibroblasts
(CAFs)
subtypes.
Marker
genes
myofibroblastic
CAFs
(myCAFs)
were
employed
establish
prognostic
model
verify
its
application
other
datasets.
Other
experiments
conducted
clinical
samples
explore
potential
risk-related
genes.
Our
bioinformatics
statistical
analyses
revealed
an
increased
proportion
epithelial
cells
NCRT
identified
Ep_c1
associated
with
better
prognosis.
Further
results
indicated
complex
communication
network
between
myCAFs.
The
top
30
marker
myCAFs
used
construct
signature
response
immunotherapy.
Finally,
Complement
C1s
subcomponent
(C1S),
Decorin
(DCN),
Neuroblastoma
suppression
tumorigenicity
1
(NBL1)
as
findings
highlight
dynamic
alterations
post-NCRT
microenvironment
provide
foundation
for
development
personalized
treatment
immunotherapeutic
approaches.
Future
studies
are
warranted
further
validate
these
their
implications.
Язык: Английский
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang,
Yujie Tang,
Dan Luo
и другие.
APL Bioengineering,
Год журнала:
2025,
Номер
9(1)
Опубликована: Март 1, 2025
Cancer-associated
fibroblasts
(CAFs)
play
a
crucial
role
in
the
tumor
microenvironment
by
promoting
growth,
immune
evasion,
and
metastasis.
Recently,
drug
delivery
systems
targeting
CAFs
have
emerged
as
promising
long-term
effective
approach
to
cancer
treatment.
Advances
nanotechnology,
particular,
led
development
of
nanomedicine
designed
specifically
target
CAFs,
offering
new
possibilities
for
precise
personalized
therapies.
This
article
reviews
recent
progress
using
nanocarriers
that
CAFs.
Additionally,
we
explore
potential
combining
multiple
therapies,
such
chemotherapy
immunotherapy,
with
enhance
efficacy
overcome
resistance.
Although
many
preclinical
studies
show
promise,
clinical
application
still
faces
considerable
challenges,
especially
terms
penetration
large-scale
production.
Therefore,
this
review
aims
provide
fresh
perspective
on
CAF-targeted
highlight
future
research
directions
applications.
Язык: Английский
CAFs activated by YAP1 upregulate cancer matrix stiffness to mediate hepatocellular carcinoma progression
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Апрель 16, 2025
The
stiffness
of
the
matrix
is
closely
related
to
progression
hepatocellular
carcinoma
(HCC).
Although
direct
targeting
stromal
rigidity
in
HCC
remains
a
clinical
challenge,
cancer-associated
fibroblasts
(CAFs)
are
considered
key
contributors
this
process.
Given
heterogeneity
CAFs,
study
explored
relationship
between
specific
CAF
subsets
and
liver
cancer
stiffness,
aiming
identify
novel
therapeutic
targets
for
patients.
Single-cell
sequencing
datasets
were
leveraged
cell
types
within
characterize
transcriptomic
profiles
CAFs.
Prognostic
analysis,
utilizing
Gene
Expression
Profiling
Interactive
Analysis
(GEPIA)
Cancer
Genome
Atlas
(TCGA)
datasets,
assessed
correlation
stiffness-related
genes
patient
outcomes.
Pseudo-time
analysis
was
applied
trace
developmental
trajectories
By
calculating
intercellular
communication
probabilities
analyzing
transcription
factor
activity,
functions
interactions
different
elucidated.
Ontology
(GO)
used
explore
functional
roles
CAFs
distinct
Yes-associated
protein
1
(YAP1)
groups.
Finally,
cellular
experiments
animal
further
conducted
validate
hypotheses
study.
This
identified
subpopulations
based
on
single-cell
data
analyzed
transcriptional
changes
these
subpopulations.
Key
findings
include
identification
collagen
type
I
alpha
(COL1A1),
III
(COL3A1),
lysyloxidase
(LOX)
as
pivotal
node
during
development.
Moreover,
expression
inversely
correlated
with
prognosis
Notably,
YAP1-positive
subpopulation
emerged
primary
contributor
cancer.
upregulates
promotes
tumor
by
activating
signaling
pathways
such
autophagy
GTPase
activity
regulation.
Cellular
studies
validated
conclusion.
uncovered
subpopulation,
particular,
shown
contribute
upregulating
relevant
promoting
through
activation
pathways.
Язык: Английский
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 17, 2025
Cancer-associated
fibroblasts
(CAFs)
are
integral
components
of
the
tumor
microenvironment
playing
key
roles
in
progression,
metastasis,
and
therapeutic
resistance.
However,
challenges
persist
understanding
their
heterogeneity,
origin,
functional
diversity.
One
major
obstacle
is
lack
standardized
naming
conventions
for
CAF
subpopulations,
with
current
systems
failing
to
capture
full
complexity.
Additionally,
identification
CAFs
hindered
by
absence
specific
biomarkers,
limiting
precision
diagnostic
strategies.
In
vitro
culture
conditions
often
fail
maintain
vivo
characteristics
CAFs,
which
complicates
study
translation
findings
clinical
practice.
Although
detection
methods,
such
as
antibodies,
mRNA
probes,
single-cell
transcriptomics,
offer
insights
into
biology,
they
standardization
provide
reliable
quantitative
measures.
Furthermore,
dynamic
interactions
between
cells,
immune
cells
within
TME
remain
insufficiently
understood,
role
evasion
therapy
resistance
an
area
ongoing
research.
Understanding
how
influence
drug
response
essential
developing
more
effective
cancer
therapies.
This
review
aims
in-depth
analysis
research,
propose
future
research
directions,
emphasize
need
improved
CAF-targeted
By
addressing
these
gaps,
it
seeks
highlight
potential
targets
overcoming
enhancing
efficacy
treatments.
Язык: Английский
Surface Molecular Markers for the Isolation of Viable Fibroblast Subpopulations in the Female Reproductive Tract: A Comprehensive Review
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
26(1), С. 233 - 233
Опубликована: Дек. 30, 2024
Advancements
in
single-cell
analyzis
technologies,
particularly
RNA
sequencing
(scRNA-seq)
and
Fluorescence-Activated
Cell
Sorting
(FACS),
have
enabled
the
of
cellular
diversity
by
providing
resolutions
that
were
not
available
previously.
These
methods
enable
simultaneous
thousands
individual
transcriptomes,
facilitating
classification
cells
into
distinct
subpopulations,
based
on
transcriptomic
differences,
adding
a
new
level
complexity
to
biomolecular
medical
research.
Fibroblasts,
despite
being
one
most
abundant
cell
types
human
body
forming
structural
backbone
tissues
organs,
remained
poorly
characterized
for
long
time.
This
is
largely
due
high
morphological
similarity
between
different
fibroblasts
lack
specific
markers
identify
subpopulations.
Once
thought
be
responsible
solely
synthesis
extracellular
matrix
(ECM)
components,
are
now
recognized
as
active
participants
diverse
physiological
processes,
including
inflammation
antimicrobial
responses.
However,
defining
molecular
profile
fibroblast
subpopulations
remains
significant
challenge.
In
this
comprehensive
review,
which
over
two
thousand
research
articles,
we
focus
identification
characterization
their
surface
markers,
with
an
emphasis
potential
targets
selective
isolation.
By
analyzing
alongside
intra-
protein
profiles,
identified
multiple
subtypes
within
female
reproductive
system.
exhibit
signatures
functional
attributes,
shaped
anatomical
localization
surrounding
or
pathological
conditions.
Our
findings
underscore
heterogeneity
roles
various
biological
contexts.
improved
understanding
paves
way
innovative
diagnostic
therapeutic
strategies,
offering
precision
targeting
subsets
clinical
applications.
Язык: Английский